Skip Header

1 - 25 of 29 results for author:"Coussens L." in Literature citations

Page of 2 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (14)

B regulatory cells and the tumor-promoting actions of TNF-alpha during squamous carcinogenesis.

Schioppa T., Moore R., Thompson R.G., Rosser E.C., Kulbe H., Nedospasov S., Mauri C., Coussens L.M., Balkwill F.R.

Proc. Natl. Acad. Sci. U.S.A. 108:10662-10667(2011) · Mapped (4)

Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.

Ursini-Siegel J., Cory S., Zuo D., Hardy W.R., Rexhepaj E., Lam S., Schade B., Jirstrom K., Bjur E., Piccirillo C.A. et al.

Cancer Res. 70:7776-7787(2010) · Mapped (5)

EMX2 is epigenetically silenced and suppresses growth in human lung cancer.

Okamoto J., Hirata T., Chen Z., Zhou H.M., Mikami I., Li H., Yagui-Beltran A., Beltran A., Johansson M., Coussens L.M. et al.

Oncogene 29:5969-5975(2010) · Mapped (1)

Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.

Masset A., Maillard C., Sounni N.E., Jacobs N., Bruyere F., Delvenne P., Tacke M., Reinheckel T., Foidart J.M., Coussens L.M. et al.

Int. J. Cancer 128:283-293(2011) · Mapped (5)

Stromal regulation of vessel stability by MMP14 and TGFbeta.

Sounni N.E., Dehne K., van Kempen L., Egeblad M., Affara N.I., Cuevas I., Wiesen J., Junankar S., Korets L., Lee J. et al.

Dis Model Mech 3:317-332(2010) · Mapped (23)

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

Andreu P., Johansson M., Affara N.I., Pucci F., Tan T., Junankar S., Korets L., Lam J., Tawfik D., DeNardo D.G. et al.

Cancer Cell 17:121-134(2010) · Mapped (5)

Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis.

Dennemarker J., Lohmuller T., Mayerle J., Tacke M., Lerch M.M., Coussens L.M., Peters C., Reinheckel T.

Oncogene 29:1611-1621(2010) · Mapped (10)

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.

DeNardo D.G., Barreto J.B., Andreu P., Vasquez L., Tawfik D., Kolhatkar N., Coussens L.M.

Cancer Cell 16:91-102(2009) · Mapped (21)

The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Kenny H.A., Kaur S., Coussens L.M., Lengyel E.

J. Clin. Invest. 118:1367-1379(2008) · Mapped (17)

Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.

Egeblad M., Shen H.C., Behonick D.J., Wilmes L., Eichten A., Korets L.V., Kheradmand F., Werb Z., Coussens L.M.

Dev. Dyn. 236:1683-1693(2007) · Mapped (7)

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent.

de Visser K.E., Korets L.V., Coussens L.M.

Cancer Cell 7:411-423(2005) · Mapped (15)

The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent.

Jodele S., Chantrain C.F., Blavier L., Lutzko C., Crooks G.M., Shimada H., Coussens L.M., Declerck Y.A.

Cancer Res. 65:3200-3208(2005) · Mapped (5)

Early neoplastic progression is complement independent.

de Visser K.E., Korets L.V., Coussens L.M.

Neoplasia 6:768-776(2004) · Mapped (6)

Matrix metalloproteinase-2 and -9 expression increases in Mycoplasma-infected airways but is not required for microvascular remodeling.

Baluk P., Raymond W.W., Ator E., Coussens L.M., McDonald D.M., Caughey G.H.

Am. J. Physiol. Lung Cell Mol. Physiol. 287:L307-17(2004) · Mapped (9)

TIMP-1 alters susceptibility to carcinogenesis.

Rhee J.S., Diaz R., Korets L., Hodgson J.G., Coussens L.M.

Cancer Res. 64:952-961(2004) · Mapped (5)

Immune enhancement of skin carcinogenesis by CD4+ T cells.

Daniel D., Meyer-Morse N., Bergsland E.K., Dehne K., Coussens L.M., Hanahan D.

J. Exp. Med. 197:1017-1028(2003) · Mapped (12)

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

Coussens L.M., Tinkle C.L., Hanahan D., Werb Z.

Cell 103:481-490(2000) · Mapped (5)

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Ullrich A., Coussens L., Hayflick J.S., Dull T.J., Gray A., Tam A.W., Lee J., Yarden Y., Libermann T.A., Schlessinger J. et al.

Nature 309:418-425(1984) · UniProtKB (1)

Sequence homology of human and mouse beta-NGF subunit genes.

Ullrich A., Gray A., Berman C., Coussens L., Dull T.J.

Cold Spring Harb. Symp. Quant. Biol. 48:435-442(1983) · UniProtKB (2) · Mapped (1)

Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways.

Coussens L., Parker P.J., Rhee L., Yang-Feng T.L., Chen E., Waterfield M.D., Francke U., Ullrich A.

Science 233:859-866(1986) · UniProtKB (4)

The complete primary structure of protein kinase C -- the major phorbol ester receptor.

Parker P.J., Coussens L., Totty N., Rhee L., Young S., Chen E., Stabel S., Waterfield M.D., Ullrich A.

Science 233:853-859(1986) · UniProtKB (1)

Alternative splicing increases the diversity of the human protein kinase C family.

Coussens L., Rhee L., Parker P.J., Ullrich A.

DNA 6:389-394(1987) · UniProtKB (1)

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

Coussens L., Yang-Feng T.L., Liao Y.C., Chen E., Gray A., McGrath J., Seeburg P.H., Libermann T.A., Schlessinger J., Francke U. et al.

Science 230:1132-1139(1985) · UniProtKB (1)

Topology of signal recognition particle receptor in endoplasmic reticulum membrane.

Lauffer L., Garcia P.D., Harkins R.N., Coussens L., Ullrich A., Walter P.

Nature 318:334-338(1985) · UniProtKB (1)

Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.

Ullrich A., Bell J.R., Chen E.Y., Herrera R., Petruzzelli L.M., Dull T.J., Gray A., Coussens L., Liao Y.-C., Tsubokawa M. et al.

Nature 313:756-761(1985) · UniProtKB (1)

to top of page·

Page of 2 | Next »